Unaudited Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
REVENUES:
Total revenues	$ 41,106	$ 216,530	$ 541,571	$ 465,446
OPERATING EXPENSES:
Research and development	1,214,029	1,219,144	3,805,617	3,032,426
General and administrative	2,503,314	1,800,159	7,180,674	5,870,745
TOTAL OPERATING EXPENSES	3,717,343	3,019,303	10,986,291	8,903,171
OPERATING LOSS	(3,676,237)	(2,802,773)	(10,444,720)	(8,437,725)
OTHER INCOME (EXPENSE):
Interest income	111,621	77,276	329,063	219,374
Interest and other expense	(230,053)	(290,773)	(805,147)	(849,457)
Change in fair value of warrant liability	5,498,391	(408,803)	(7,581,521)	7,017,923
TOTAL OTHER INCOME (EXPENSE)	5,379,959	(622,300)	(8,057,605)	6,387,840
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES	1,703,722	(3,425,073)	(18,502,325)	(2,049,885)
Income taxes
NET INCOME (LOSS)	1,703,722	(3,425,073)	(18,502,325)	(2,049,885)
Preferred dividends and beneficial conversion feature	(311,136)		(13,433,397)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ 1,392,586	$ (3,425,073)	$ (31,935,722)	$ (2,049,885)
Net income (loss) per common share - basic (in dollars per share)	$ 0.09	$ (0.39)	$ (3.60)	$ (0.23)
Net income (loss) per common share - diluted (in dollars per share)	$ 0.09	$ (0.39)	$ (3.60)	$ (0.23)
Weighted average shares of common shares - basic (in shares)	8,921,345	8,735,790	8,860,168	8,730,303
Weighted average shares of common shares - diluted (in shares)	8,936,255	8,735,790	8,860,168	8,730,303
Grant [Member]
REVENUES:
Total revenues	$ 41,106	$ 216,530	$ 541,571	$ 465,446